MA44010A - Formulations pharmaceutiques de billes comprenant du diméthylfumarate - Google Patents
Formulations pharmaceutiques de billes comprenant du diméthylfumarateInfo
- Publication number
- MA44010A MA44010A MA044010A MA44010A MA44010A MA 44010 A MA44010 A MA 44010A MA 044010 A MA044010 A MA 044010A MA 44010 A MA44010 A MA 44010A MA 44010 A MA44010 A MA 44010A
- Authority
- MA
- Morocco
- Prior art keywords
- dimethylfumarate
- pharmaceutical formulations
- formulations including
- ball
- ball pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662294054P | 2016-02-11 | 2016-02-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA44010A true MA44010A (fr) | 2018-12-19 |
Family
ID=58057304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA044010A MA44010A (fr) | 2016-02-11 | 2017-02-08 | Formulations pharmaceutiques de billes comprenant du diméthylfumarate |
Country Status (12)
Country | Link |
---|---|
US (2) | US11033509B2 (fr) |
EP (1) | EP3413879A1 (fr) |
JP (2) | JP6902043B2 (fr) |
KR (1) | KR20180108814A (fr) |
CN (1) | CN108778256A (fr) |
AU (1) | AU2017217464B2 (fr) |
CA (1) | CA3013472A1 (fr) |
EA (1) | EA201891803A1 (fr) |
IL (1) | IL261073A (fr) |
MA (1) | MA44010A (fr) |
MX (1) | MX2018009749A (fr) |
WO (1) | WO2017139331A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2017217464B2 (en) * | 2016-02-11 | 2022-11-10 | Biogen Ma Inc. | Pharmaceutical bead formulations comprising dimethyl fumarate |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2801354T (pt) * | 2004-10-08 | 2017-06-05 | Forward Pharma As | Composições farmacêuticas de libertação controlada compreendendo um éster de ácido fumárico |
US20080187579A1 (en) * | 2007-02-01 | 2008-08-07 | Pavan Bhat | Extended-release dosage form |
US20130216615A1 (en) * | 2012-02-07 | 2013-08-22 | David Goldman | Pharmaceutical Compositions Containing Dimethyl Fumarate |
WO2015042294A1 (fr) | 2013-09-18 | 2015-03-26 | Xenoport, Inc. | Compositions de nanoparticules de fumarate de diméthyle |
EP3079663A1 (fr) | 2013-12-13 | 2016-10-19 | Biogen MA Inc. | Forme pharmaceutique à libération contrôlée pour administration une fois par jour de fumarate de diméthyle |
MA40982A (fr) * | 2014-11-19 | 2017-09-26 | Biogen Ma Inc | Formulation de bille pharmaceutique comprenant du fumarate de diméthyle |
MA42196A (fr) | 2015-06-17 | 2018-04-25 | Biogen Ma Inc | Particules de fumarate de diméthyle et leurs compositions pharmaceutiques |
CN104971048B (zh) * | 2015-07-01 | 2019-01-18 | 上海汇伦医药科技有限公司 | 富马酸二甲酯肠溶微丸及其制备方法 |
AU2017217464B2 (en) * | 2016-02-11 | 2022-11-10 | Biogen Ma Inc. | Pharmaceutical bead formulations comprising dimethyl fumarate |
-
2017
- 2017-02-08 AU AU2017217464A patent/AU2017217464B2/en not_active Expired - Fee Related
- 2017-02-08 EP EP17706072.0A patent/EP3413879A1/fr not_active Withdrawn
- 2017-02-08 CA CA3013472A patent/CA3013472A1/fr active Pending
- 2017-02-08 KR KR1020187025947A patent/KR20180108814A/ko not_active Application Discontinuation
- 2017-02-08 US US16/076,849 patent/US11033509B2/en active Active
- 2017-02-08 WO PCT/US2017/016934 patent/WO2017139331A1/fr active Application Filing
- 2017-02-08 CN CN201780016727.0A patent/CN108778256A/zh active Pending
- 2017-02-08 MA MA044010A patent/MA44010A/fr unknown
- 2017-02-08 MX MX2018009749A patent/MX2018009749A/es unknown
- 2017-02-08 EA EA201891803A patent/EA201891803A1/ru unknown
- 2017-02-08 JP JP2018542269A patent/JP6902043B2/ja active Active
-
2018
- 2018-08-09 IL IL261073A patent/IL261073A/en unknown
-
2021
- 2021-05-13 US US17/319,694 patent/US20210369629A1/en not_active Abandoned
- 2021-06-18 JP JP2021101599A patent/JP2021152050A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EA201891803A1 (ru) | 2019-01-31 |
WO2017139331A1 (fr) | 2017-08-17 |
US11033509B2 (en) | 2021-06-15 |
MX2018009749A (es) | 2019-02-07 |
CA3013472A1 (fr) | 2017-08-17 |
WO2017139331A8 (fr) | 2017-10-12 |
JP6902043B2 (ja) | 2021-07-14 |
EP3413879A1 (fr) | 2018-12-19 |
IL261073A (en) | 2018-10-31 |
US20210369629A1 (en) | 2021-12-02 |
US20190046456A1 (en) | 2019-02-14 |
JP2019504859A (ja) | 2019-02-21 |
KR20180108814A (ko) | 2018-10-04 |
JP2021152050A (ja) | 2021-09-30 |
CN108778256A (zh) | 2018-11-09 |
AU2017217464A1 (en) | 2018-08-30 |
AU2017217464B2 (en) | 2022-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA50541A (fr) | Formulations pharmaceutiques | |
MA42844A (fr) | Combinaisons thérapeutiques comprenant des immunoconjugués anti-folr1 | |
MA42303A (fr) | Formulations pharmaceutiques | |
MA46867A (fr) | Formulations pharmaceutiques | |
DK3634377T3 (da) | Farmaceutisk formulering | |
MA54716A (fr) | Réduction de la viscosité de formulations pharmaceutiques | |
ES2972844T3 (es) | Preparación farmacéutica | |
DK3709978T3 (da) | Farmaceutisk oral formulering omfattende bakterier | |
MA43705A (fr) | Formulation pharmaceutique | |
MA44987A (fr) | Formulations de médicaments améliorées | |
MA45187A (fr) | Combinaisons pharmaceutiques | |
MA40982A (fr) | Formulation de bille pharmaceutique comprenant du fumarate de diméthyle | |
MA49837A (fr) | Compositions pharmaceutiques | |
MA49977A (fr) | Combinaisons pharmaceutiques comprenant un anticorps anti-ly75 | |
MA55015A (fr) | Formulations pharmaceutiques | |
IL266537A (en) | pharmaceutical preparation | |
MA49822A (fr) | Combinaison pharmaceutique comprenant du ponesimod | |
MA44079A (fr) | Compositions pharmaceutiques comprenant un dérivé de phénylaminopyrimidine | |
DK3280447T3 (da) | Farmaceutiske formuleringer | |
DK3601277T3 (da) | Farmaceutisk formulering | |
ZA201807851B (en) | Pharmaceutical formulation | |
MA54095A (fr) | Formulations pharmaceutiques aqueuses | |
MA44010A (fr) | Formulations pharmaceutiques de billes comprenant du diméthylfumarate | |
MA40990A (fr) | Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle | |
IL275144A (en) | Pharmacy preparation |